Shenoy GN[au] - Search Results

Year	Number of Results
2010	1
2011	1
2012	1
2014	1
2015	1
2017	1
2018	2
2020	2
2021	5
2022	3
2024	0

1

When Little Things Make a Big Difference.

Shenoy GN. Shenoy GN. Immunol Invest. 2020 Oct;49(7):692-697. doi: 10.1080/08820139.2020.1831774. Immunol Invest. 2020. PMID: 33043772 No abstract available.

2

Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines.

Hofman K, Shenoy GN, Chak V, Balu-Iyer SV. Hofman K, et al. Among authors: shenoy gn. Immunol Invest. 2021 Oct;50(7):743-779. doi: 10.1080/08820139.2021.1904977. Epub 2021 Apr 30. Immunol Invest. 2021. PMID: 33929280 Free PMC article. Review.

3

The impact of EMTALA on medical malpractice framework models: a review.

Shenoy A, Shenoy GN, Shenoy GG. Shenoy A, et al. Among authors: shenoy gn. Patient Saf Surg. 2022 Jun 24;16(1):21. doi: 10.1186/s13037-022-00325-w. Patient Saf Surg. 2022. PMID: 35751085 Free PMC article. Review.

4

The Stark law, from inception to COVID-19 blanket waivers: a review.

Shenoy A, Shenoy GN, Shenoy GG. Shenoy A, et al. Among authors: shenoy gn. Patient Saf Surg. 2022 Jun 2;16(1):19. doi: 10.1186/s13037-022-00326-9. Patient Saf Surg. 2022. PMID: 35655312 Free PMC article. Review.

5

Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments.

Shenoy GN, Bhatta M, Bankert RB. Shenoy GN, et al. Cells. 2021 Nov 13;10(11):3155. doi: 10.3390/cells10113155. Cells. 2021. PMID: 34831378 Free PMC article. Review.

6

Patient safety assurance in the age of defensive medicine: a review.

Shenoy A, Shenoy GN, Shenoy GG. Shenoy A, et al. Among authors: shenoy gn. Patient Saf Surg. 2022 Feb 17;16(1):10. doi: 10.1186/s13037-022-00319-8. Patient Saf Surg. 2022. PMID: 35177113 Free PMC article.

7

Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins.

Nguyen NH, Glassman FY, Dingman RK, Shenoy GN, Wohlfert EA, Kay JG, Bankert RB, Balu-Iyer SV. Nguyen NH, et al. Among authors: shenoy gn. Sci Rep. 2021 Sep 8;11(1):17853. doi: 10.1038/s41598-021-97333-0. Sci Rep. 2021. PMID: 34497305 Free PMC article.

8

Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments.

Bhatta M, Shenoy GN, Loyall JL, Gray BD, Bapardekar M, Conway A, Minderman H, Kelleher RJ Jr, Carreno BM, Linette G, Shultz LD, Odunsi K, Balu-Iyer SV, Pak KY, Bankert RB. Bhatta M, et al. Among authors: shenoy gn. J Immunother Cancer. 2021 Oct;9(10):e003148. doi: 10.1136/jitc-2021-003148. J Immunother Cancer. 2021. PMID: 34599030 Free PMC article.

9

Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses.

Shenoy GN, Loyall J, Maguire O, Iyer V, Kelleher RJ Jr, Minderman H, Wallace PK, Odunsi K, Balu-Iyer SV, Bankert RB. Shenoy GN, et al. Cancer Immunol Res. 2018 Feb;6(2):236-247. doi: 10.1158/2326-6066.CIR-17-0113. Epub 2018 Jan 4. Cancer Immunol Res. 2018. PMID: 29301753 Free PMC article.

10

Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

Shenoy GN, Loyall J, Berenson CS, Kelleher RJ Jr, Iyer V, Balu-Iyer SV, Odunsi K, Bankert RB. Shenoy GN, et al. J Immunol. 2018 Dec 15;201(12):3750-3758. doi: 10.4049/jimmunol.1801041. Epub 2018 Nov 16. J Immunol. 2018. PMID: 30446565 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year